Pan‐cancer multi‐omics analysis revealed significant correlations between TP53 mutation status, intratumoral microbiome diversity (particularly in HCC and EC) and altered tumour microenvironment (TME) components, such as reduced endothelial cell abundance. This evidence concerns the gene TP53 and hepatocellular carcinoma.